Dual-Pharmacophore DNA-Encoded Chemical Libraries for Drug Discovery

DNA-encoded chemical libraries allow synthesis and screening of chemical compound collections of unprecedented size and diversity. This chapter by Jörg Scheuermann of ETH Zurich reviews concepts and applications related to Dual-pharmacophore DNA-encoded chemical libraries, characterizing a chelate effect improvement of ≥1000-fold for bidentate binding. The technology represents a complement to conventional fragment-based lead discovery strategies.

Use Cases

• Screen for novel drug leads based on combinatorial self-assembly of two complementary sublibraries.
• Analyze binding affinity improvements based on the described ≥1000-fold chelate effect for bidentate binding.
• Design fragment-based drug discovery experiments based on the dual-pharmacophore library strategy.
• Study molecular interactions using DNA-scaffolded pairs of binding molecules with defined spatial arrangements.

Strengths

• Describes a technology enabling libraries of unprecedented size and diversity.
• Quantifies a ≥1000-fold improvement for the bidentate binding mode compared to monodentate binding.
• Authored by a researcher from a recognized institution (ETH Zurich).

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count and file formats are unknown, which may limit suitability assessment.

Provenance

Source

Jörg Scheuermann, ETH Zurich

Collection Method

Likely contains synthesized research data and analysis from the described chemical library experiments.